Literature DB >> 7300921

Lipid and lysosomal enzymes in human fibroblasts cultured with perhexiline maleate.

S Albouz, J M Boutry, G Dubois, R Bourdon, J J Hauw, N Baumann.   

Abstract

To understand the mechanism of the lysosomal lipid storage induced by perhexiline maleate, we performed simultaneous lipid analysis and lysosomal enzymes determinations. Human fibroblasts were cultured for 5 days in the presence of perhexiline maleate at a concentration of 2 micrograms/ml of culture medium. Lipid analysis showed that those non toxic levels determined the same changes as seen with higher concentrations of the drug (Hauw et al. 1980) i. e. increase of cholesterol and of all major phospholipids. Qualitative phospholipid pattern was not markedly changed. Lysosomal enzymes activities were not modified with the exception of sphingomyelinase which was reduced to 12% of its normal level.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7300921     DOI: 10.1007/bf00500076

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  27 in total

1.  Polyneuropathy after perhexiline maleate therapy.

Authors:  F Lhermitte; M Fardeau; F Chedru; J Mallecourt
Journal:  Br Med J       Date:  1976-05-22

2.  [Diffuse polymorphous inclusions in a patient treated with perhexiline maleate (author's transl)].

Authors:  J J Hauw; B Singer; R Poupon; D Lecomte; P P de Saint-Maur; A Lageron; S Pollet
Journal:  Nouv Presse Med       Date:  1978-03-11

3.  Accumulation of a glycerolphospholipid in classical niemann-pick disease.

Authors:  G Rouser; G Kritchevsky; A G Knudson; G Simon
Journal:  Lipids       Date:  1968-05       Impact factor: 1.880

4.  Arylsulfatases isoenzymes in metachromatic leucodystrophy/detection of a new variant by electrophoresis improvement of quantitative assay.

Authors:  G Dubois; J C Turpin; N Baumann
Journal:  Biomedicine       Date:  1975-04-10

Review 5.  Drug-induced experimental lipidosis in the nervous system.

Authors:  D Drenckhahn; R Lüllmann-Rauch
Journal:  Neuroscience       Date:  1979       Impact factor: 3.590

6.  Lysosomal bis (monoacylglycero)phosphate of rat liver, its induction by chloroquine and its structure.

Authors:  H B Tjiong; H Debuch
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1978-01

7.  Direct thin-layer chromatography of gangliosides of a total lipid extract.

Authors:  S Harth; H Dreyfus; P F Urban; P Mandel
Journal:  Anal Biochem       Date:  1978-06-01       Impact factor: 3.365

8.  Muscle and nerve changes induced by perhexiline maleate in man and mice.

Authors:  M Fardeau; F M Tomé; P Simon
Journal:  Muscle Nerve       Date:  1979 Jan-Feb       Impact factor: 3.217

9.  Microanalysis of brain lipids: multiple two-dimensional thin-layer chromatography.

Authors:  S Pollet; S Ermidou; F Le Saux; M Monge; N Baumann
Journal:  J Lipid Res       Date:  1978-09       Impact factor: 5.922

10.  Perhexiline maleate-induced lipidosis in cultured human fibroblasts: cell kinetics, ultrastructural and biochemical studies.

Authors:  J J Hauw; J M Boutry; S Albouz; M L Harpin; M Baudrimont; R Escourolle; N Baumann
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1980
View more
  4 in total

1.  Tumor necrosis factor-alpha induces stress fiber formation through ceramide production: role of sphingosine kinase.

Authors:  A N Hanna; L G Berthiaume; Y Kikuchi; D Begg; S Bourgoin; D N Brindley
Journal:  Mol Biol Cell       Date:  2001-11       Impact factor: 4.138

2.  Evidence against involvement of the acid lysosomal sphingomyelinase in the tumor-necrosis-factor- and interleukin-1-induced sphingomyelin cycle and cell proliferation in human fibroblasts.

Authors:  N Andrieu; R Salvayre; T Levade
Journal:  Biochem J       Date:  1994-10-15       Impact factor: 3.857

3.  The effects of perhexiline maleate on low density lipoprotein processing and cholesterol metabolism in cultured human fibroblasts.

Authors:  C Candide; J C Mazière; C Mazière; A Lageron; J Polonovski
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

4.  Characterization of the small molecule ARC39, a direct and specific inhibitor of acid sphingomyelinase in vitro.

Authors:  Eyad Naser; Stephanie Kadow; Fabian Schumacher; Zainelabdeen H Mohamed; Christian Kappe; Gabriele Hessler; Barbara Pollmeier; Burkhard Kleuser; Christoph Arenz; Katrin Anne Becker; Erich Gulbins; Alexander Carpinteiro
Journal:  J Lipid Res       Date:  2020-03-10       Impact factor: 5.922

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.